Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,962 | -4,348 | -20,848 | -16,552 | -11,441 |
| Depreciation Amortization | 40 | 19 | 53 | 34 | 21 |
| Other Working Capital | 149 | 254 | 3,418 | 2,100 | 1,394 |
| Other Operating Activity | 1,721 | 1,486 | 2,394 | 1,735 | 1,197 |
| Operating Cash Flow | $-5,053 | $-2,588 | $-14,983 | $-12,683 | $-8,829 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -143 | -144 | -8 |
| Sale Of Investment | N/A | N/A | 1,231 | 1,231 | 1,231 |
| Other Investing Activity | 42 | 42 | 33 | -4 | 69 |
| Investing Cash Flow | $42 | $42 | $1,121 | $1,083 | $1,293 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,000 | 1,000 | 10,000 | 10,000 | 10,000 |
| Common Stock Issued | 1,000 | 1,000 | 1,003 | 3 | 3 |
| Other Financing Activity | 2,975 | 975 | 0 | 0 | 0 |
| Financing Cash Flow | $4,975 | $2,975 | $11,003 | $10,003 | $10,003 |
| Beginning Cash Position | 74 | 74 | 2,933 | 2,933 | 2,933 |
| End Cash Position | 38 | 502 | 74 | 1,336 | 5,399 |
| Net Cash Flow | $-36 | $428 | $-2,859 | $-1,598 | $2,466 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,053 | -2,588 | -14,983 | -12,683 | -8,829 |
| Capital Expenditure | N/A | N/A | -143 | -144 | -8 |
| Free Cash Flow | -5,053 | -2,588 | -15,126 | -12,827 | -8,837 |